Success Stories: EB1-B Approval for an Oncology Postdoctoral Fellow in 21 days
Client's Testimonial:
Great!!!!!!! Awesome !!!!Thank you so much. You really did a great job.
On June 4th, 2013, we received another EB-1B (Outstanding Professor or Researcher) Approval for a Postdoctoral Fellow in the Field of Oncology Working for one of Louisiana's Largest Employing Universities (Approval Notice)
General Field: Oncology Petitioner: One of Louisiana's largest employing universities Position at the Time of Case Filing: Postdoctoral Fellow National Origin: India Service Center: Texas Service Center (TSC) State Residing at the Time of Filing: Louisiana Approval Notice Date: June 4, 2013 Processing Time: 21 days (after upgrading to premium processing)
Case Summary:
For this EB1-B case, the beneficiary is a postdoctoral fellow in the field of oncology specializing in cancer signaling and the role endocrine plays in cancer development. Successful research in his field of endeavor develops a better understanding of current treatments for prostate and breast cancers, and it also provides new directions for the development of therapies that are more effective and safer, which in turn leads to a higher standard of patient care and better public health outcomes. Our client wishes to continue working at one of Louisiana’s largest employing universities. In this case, the petitioner is one of the most highly regarded and selective independent research universities in the United States. With 4,400 employees, this university is the largest employer in New Orleans. To prove that the beneficiary was internationally recognized in his research, we highlighted his research work, which resulted in at least 17 peer-reviewed scholarly articles accepted or published in leading journals and 16 conference presentations and proceedings. Furthermore, his publications have been cited at least 159 times by researchers around the world. In addition to this beneficiary’s academic successes, we had to supply further evidence to meet the standards set by the law. We did this by obtaining the highest quality of recommendation letters from both this beneficiary’s current colleagues as well as unaffiliated researchers in this beneficiary’s field of study. His expertise can be seen in this quote by an independent recommender, “Without [the beneficiary’s] significant influence and monumental cancer-related discoveries, the medical research field would be lacking one of the most capable and driven researchers working today. It is of the utmost importance to retain his presence and therefore his abilities in the United States, so that he can continue the steady advancement of cancer-related knowledge and treatment in the nation.” Our client’s case was approved in just 3 weeks.